Allon Therapeutics' Series A Round

Allon Therapeutics raised a round of funding on December 08, 2003.

Allon Therapeutics Inc. is a clinical-stage biotechnology company developing treatments for major neurodegenerative conditions. Allon has 3 Phase II human efficacy trials underway pursuing three large…

Articles about Allon Therapeutics' Series A Round: